Acquired Alpha-2 Anti-Plasmin Deficiency Secondary to Amyloidosis

• References

• 1 Bowie E JW, Maldonado E, Brown AL. et al Intravascular coagulation in systemic amyloidosis. Thrombosis Diathesis Haemor-rhagica 1969; (Suppl) 305-312
• 2 Burdic CO. Lipidosis of spleen with thrombocytopenic purpura, leukocytosis, and amyloidosis. Arch Pathol 1965; 79: 583-587
• 3 Furie B, Greene E, Furie BC. Syndrome of acquired Factor X deficiency and systemic amyloidosis. N Engl J Med 1977; 297: 81-85
• 4 McPherson RA, Onstad JW, Ogoretz RJ. et al Coagulopathy in amyloidosis: combined deficiency of Factors IX and X. Am J Hematol 1977; 3: 225-235
• 5 Liebman H, Chinowsky M, Valdin J. et al Increased fibrinolysis and amyloidosis. Arch Int Med 1983; 678-682
• 6 Chang JC, Kane KK. Pathologic hyperfibrinolysis associated with amyloidosis: Clinical response to epsilon amino caproic acid. Am J Clin Pathol 1984; 81: 382-387
• 7 Meyer K, Williams EC. Fibrinolysis and acquired alpha 2 plasmin inhibitor deficiency in amyloidosis. Am J Med 1985; 79: 394-396
• 8 Takashi H, Koike X, Yoshida N, Kitahara O, Hanano M, Shibata A, Aoki N. Excessive fibrinolysis in suspected amyloidosis: demonstration of plasmin - alpha 2 - plasmin inhibitor complex and von Willebrand factor fragment in plasma. Am J Hematol 1986; 23: 153-166
• 9 Lawson DE, Mitchell GA, Huseby RM. A sensitive fluorescent assay for determining alpha-2 plasmin inhibitor using a synthetic substrate. Thromb Res 1979; 14: 323